Oksana Moskalyk, O. Semenyuk, Myroslav Kruk, V. Hayevskyy, O. Tynitovska, O. Chorniy, Ira von-Nagy, Nataliya Pidkovka
{"title":"新冠肺炎患者化学感觉功能障碍的研究","authors":"Oksana Moskalyk, O. Semenyuk, Myroslav Kruk, V. Hayevskyy, O. Tynitovska, O. Chorniy, Ira von-Nagy, Nataliya Pidkovka","doi":"10.25040/ntsh2022.01.13","DOIUrl":null,"url":null,"abstract":"Introduction. Olfactory disorders are observed in infectious and non-infectious diseases, but caused a new wave of attention as one of the fi rst and often the only symptoms of COVID-19 at the beginning of the pandemic. Aim. To evaluate the prevalence, degree, duration of olfactory and taste disorders in patients with COVID-19, their relationship with the severity of the disease and the impact on the quality of life. Materials and methods. 699 patients after COVID-19 were interviewed using the electronic questionnaire, which was developed based on the available data and our observations about the most common symptoms in COVID-19 patients. The questionnaire consisted of 35 main questions on the topic of the study organized in 3 sections. Response forms were closed, semi-closed or open. Two questions on screening for mood disorders were taken from the Patient Health Questionnaire (PHQ). Patients were asked to rate their sense of smell and taste on a 10-point visual analog scale (VAS). Results. In most cases, olfactory and taste impairment occurred immediately after the appearance of other symptoms reaching a peak on 3-5th days of illness and did not improve after clinical recovery. Patients experienced varying degrees of hypo-, par- and cacosmia, subsequently even changing their food and behavioral habits (such as reducing or quitting smoking). Conclusions. The recovery of smell and taste had a clear direct correlation. More than half of the patients needed an in-depth assessment of their mental health most likely due to the combination of factors, including the impairment of smell and taste.","PeriodicalId":140699,"journal":{"name":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"THE STUDY OF CHEMOSENSORY DYSFUNCTION IN PATIENTS AFTER COVID-19\",\"authors\":\"Oksana Moskalyk, O. Semenyuk, Myroslav Kruk, V. Hayevskyy, O. Tynitovska, O. Chorniy, Ira von-Nagy, Nataliya Pidkovka\",\"doi\":\"10.25040/ntsh2022.01.13\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction. Olfactory disorders are observed in infectious and non-infectious diseases, but caused a new wave of attention as one of the fi rst and often the only symptoms of COVID-19 at the beginning of the pandemic. Aim. To evaluate the prevalence, degree, duration of olfactory and taste disorders in patients with COVID-19, their relationship with the severity of the disease and the impact on the quality of life. Materials and methods. 699 patients after COVID-19 were interviewed using the electronic questionnaire, which was developed based on the available data and our observations about the most common symptoms in COVID-19 patients. The questionnaire consisted of 35 main questions on the topic of the study organized in 3 sections. Response forms were closed, semi-closed or open. Two questions on screening for mood disorders were taken from the Patient Health Questionnaire (PHQ). Patients were asked to rate their sense of smell and taste on a 10-point visual analog scale (VAS). Results. In most cases, olfactory and taste impairment occurred immediately after the appearance of other symptoms reaching a peak on 3-5th days of illness and did not improve after clinical recovery. Patients experienced varying degrees of hypo-, par- and cacosmia, subsequently even changing their food and behavioral habits (such as reducing or quitting smoking). Conclusions. The recovery of smell and taste had a clear direct correlation. More than half of the patients needed an in-depth assessment of their mental health most likely due to the combination of factors, including the impairment of smell and taste.\",\"PeriodicalId\":140699,\"journal\":{\"name\":\"Proceedings of the Shevchenko Scientific Society. Medical Sciences\",\"volume\":\"1 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Proceedings of the Shevchenko Scientific Society. Medical Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25040/ntsh2022.01.13\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Proceedings of the Shevchenko Scientific Society. Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25040/ntsh2022.01.13","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
THE STUDY OF CHEMOSENSORY DYSFUNCTION IN PATIENTS AFTER COVID-19
Introduction. Olfactory disorders are observed in infectious and non-infectious diseases, but caused a new wave of attention as one of the fi rst and often the only symptoms of COVID-19 at the beginning of the pandemic. Aim. To evaluate the prevalence, degree, duration of olfactory and taste disorders in patients with COVID-19, their relationship with the severity of the disease and the impact on the quality of life. Materials and methods. 699 patients after COVID-19 were interviewed using the electronic questionnaire, which was developed based on the available data and our observations about the most common symptoms in COVID-19 patients. The questionnaire consisted of 35 main questions on the topic of the study organized in 3 sections. Response forms were closed, semi-closed or open. Two questions on screening for mood disorders were taken from the Patient Health Questionnaire (PHQ). Patients were asked to rate their sense of smell and taste on a 10-point visual analog scale (VAS). Results. In most cases, olfactory and taste impairment occurred immediately after the appearance of other symptoms reaching a peak on 3-5th days of illness and did not improve after clinical recovery. Patients experienced varying degrees of hypo-, par- and cacosmia, subsequently even changing their food and behavioral habits (such as reducing or quitting smoking). Conclusions. The recovery of smell and taste had a clear direct correlation. More than half of the patients needed an in-depth assessment of their mental health most likely due to the combination of factors, including the impairment of smell and taste.